Gill, P. S., & Grewal, N. (2017). Mirabegron: first β3 agonist in treatment of overactive bladder. International Journal of Basic & Clinical Pharmacology, 1(2), 120–121. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1410